Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%...
Saved in:
Main Authors: | Linda Aurpibul, Thanyawee Puthanakit, Thira Sirisanthana, Virat Sirisanthana |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951814475&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
by: Mongkol Lao-araya, et al.
Published: (2018) -
Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk
by: Linda Aurpibul, et al.
Published: (2018)